Electrocorticography During Deep Brain Stimulation Surgery: Safety Experience From 4 Centers Within the National Institute of Neurological Disorders and Stroke Research Opportunities in Human Consortium.


Journal

Neurosurgery
ISSN: 1524-4040
Titre abrégé: Neurosurgery
Pays: United States
ID NLM: 7802914

Informations de publication

Date de publication:
15 04 2021
Historique:
received: 17 06 2020
accepted: 20 11 2020
pubmed: 13 2 2021
medline: 6 7 2021
entrez: 12 2 2021
Statut: ppublish

Résumé

Intraoperative research during deep brain stimulation (DBS) surgery has enabled major advances in understanding movement disorders pathophysiology and potential mechanisms for therapeutic benefit. In particular, over the last decade, recording electrocorticography (ECoG) from the cortical surface, simultaneously with subcortical recordings, has become an important research tool for assessing basal ganglia-thalamocortical circuit physiology. To provide confirmation of the safety of performing ECoG during DBS surgery, using data from centers involved in 2 BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative-funded basic human neuroscience projects. Data were collected separately at 4 centers. The primary endpoint was complication rate, defined as any intraoperative event, infection, or postoperative magnetic resonance imaging abnormality requiring clinical follow-up. Complication rates for explanatory variables were compared using point biserial correlations and Fisher exact tests. A total of 367 DBS surgeries involving ECoG were reviewed. No cortical hemorrhages were observed. Seven complications occurred: 4 intraparenchymal hemorrhages and 3 infections (complication rate of 1.91%; CI = 0.77%-3.89%). The placement of 2 separate ECoG research electrodes through a single burr hole (84 cases) did not result in a significantly different rate of complications, compared to placement of a single electrode (3.6% vs 1.5%; P = .4). Research data were obtained successfully in 350 surgeries (95.4%). Combined with the single report previously available, which described no ECoG-related complications in a single-center cohort of 200 cases, these findings suggest that research ECOG during DBS surgery did not significantly alter complication rates.

Sections du résumé

BACKGROUND
Intraoperative research during deep brain stimulation (DBS) surgery has enabled major advances in understanding movement disorders pathophysiology and potential mechanisms for therapeutic benefit. In particular, over the last decade, recording electrocorticography (ECoG) from the cortical surface, simultaneously with subcortical recordings, has become an important research tool for assessing basal ganglia-thalamocortical circuit physiology.
OBJECTIVE
To provide confirmation of the safety of performing ECoG during DBS surgery, using data from centers involved in 2 BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative-funded basic human neuroscience projects.
METHODS
Data were collected separately at 4 centers. The primary endpoint was complication rate, defined as any intraoperative event, infection, or postoperative magnetic resonance imaging abnormality requiring clinical follow-up. Complication rates for explanatory variables were compared using point biserial correlations and Fisher exact tests.
RESULTS
A total of 367 DBS surgeries involving ECoG were reviewed. No cortical hemorrhages were observed. Seven complications occurred: 4 intraparenchymal hemorrhages and 3 infections (complication rate of 1.91%; CI = 0.77%-3.89%). The placement of 2 separate ECoG research electrodes through a single burr hole (84 cases) did not result in a significantly different rate of complications, compared to placement of a single electrode (3.6% vs 1.5%; P = .4). Research data were obtained successfully in 350 surgeries (95.4%).
CONCLUSION
Combined with the single report previously available, which described no ECoG-related complications in a single-center cohort of 200 cases, these findings suggest that research ECOG during DBS surgery did not significantly alter complication rates.

Identifiants

pubmed: 33575799
pii: 6133600
doi: 10.1093/neuros/nyaa592
pmc: PMC8190459
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

E420-E426

Subventions

Organisme : NINDS NIH HHS
ID : U01 NS098961
Pays : United States
Organisme : NINDS NIH HHS
ID : U01 NS098969
Pays : United States
Organisme : NINDS NIH HHS
ID : U01 NS103792
Pays : United States
Organisme : NINDS NIH HHS
ID : U01 NS117839
Pays : United States

Informations de copyright

© Congress of Neurological Surgeons 2021.

Références

Brain Stimul. 2018 May - Jun;11(3):607-617
pubmed: 29422442
J Neurosurg. 2017 Jan;126(1):122-131
pubmed: 26918474
J Neurosci. 2013 Apr 24;33(17):7220-33
pubmed: 23616531
J Neurosurg. 2018 Feb;128(2):605-616
pubmed: 28409730
Mov Disord. 2016 Dec;31(12):1846-1853
pubmed: 27474845
Stereotact Funct Neurosurg. 2018;96(5):311-319
pubmed: 30326475
J Neural Eng. 2018 Oct;15(5):056016
pubmed: 29972146
Neurobiol Dis. 2013 Jun;54:464-74
pubmed: 23388190
J Neurosci. 2018 May 9;38(19):4556-4568
pubmed: 29661966
Nat Neurosci. 2015 Jul;18(7):1041-50
pubmed: 26053402
Neurotherapeutics. 2019 Jan;16(1):105-118
pubmed: 30607748
Nature. 2010 Apr 8;464(7290):903-7
pubmed: 20336071
Brain. 2012 Feb;135(Pt 2):615-30
pubmed: 22252995
Neuron. 2019 Feb 6;101(3):394-398
pubmed: 30731065
Neurobiol Dis. 2016 Feb;86:177-86
pubmed: 26639855
J Neurosci. 2016 Jun 15;36(24):6445-58
pubmed: 27307233
Nat Neurosci. 2017 Apr;20(4):590-601
pubmed: 28218914
J Neurosci. 2019 Apr 3;39(14):2698-2708
pubmed: 30700532
J Neurosci. 2017 May 3;37(18):4830-4840
pubmed: 28416595
Clin Neurophysiol. 2012 Nov;123(11):2232-8
pubmed: 22633916
Brain. 2018 Jan 1;141(1):205-216
pubmed: 29190362
J Neurosci. 2016 Nov 9;36(45):11489-11495
pubmed: 27911752
Curr Biol. 2018 May 7;28(9):1333-1343.e4
pubmed: 29657115
JAMA Neurol. 2015 Nov;72(11):1244-51
pubmed: 26409266
Brain. 2016 Aug;139(Pt 8):2211-23
pubmed: 27329771
Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4780-5
pubmed: 23471992
Nat Neurosci. 2015 May;18(5):779-86
pubmed: 25867121
J Neurosci. 2018 Oct 24;38(43):9129-9141
pubmed: 30201770
Neuroimage. 2016 Jan 15;125:515-521
pubmed: 26520771
Elife. 2017 Jul 25;6:
pubmed: 28742498
Neuron. 2019 Jan 2;101(1):165-177.e5
pubmed: 30528064
J Neurophysiol. 2017 Sep 1;118(3):1472-1487
pubmed: 28592690
J Neurosurg. 2017 Sep;127(3):580-587
pubmed: 27858575
Neuroimage. 2020 Aug 15;217:116904
pubmed: 32387742

Auteurs

Nathaniel D Sisterson (ND)

Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

April A Carlson (AA)

Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, California, USA.

Ueli Rutishauser (U)

Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Center for Neural Science and Medicine, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Computation and Neural Systems, Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA.

Adam N Mamelak (AN)

Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, California, USA.

Mitchell Flagg (M)

Department of Neurosurgery, University of California, Los Angeles, Los Angeles, California, USA.

Nader Pouratian (N)

Department of Neurosurgery, University of California, Los Angeles, Los Angeles, California, USA.

Yousef Salimpour (Y)

Department of Neurological Surgery, Johns Hopkins University, Baltimore, Maryland, USA.

William S Anderson (WS)

Department of Neurological Surgery, Johns Hopkins University, Baltimore, Maryland, USA.

R Mark Richardson (RM)

Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Harvard Medical School, Boston, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH